Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.

EVG

Evgen Pharma (EVG)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:EVG
DataOraFonteTitoloSimboloCompagnia
17/01/201710:23Alliance NewsAlliance NewsEvgen Pharma Doses First Breast Cancer Trial Patients; Hires New CFOLSE:EVGEvgen Pharma Plc
17/01/201708:00UK RegulatoryEvgen Pharma PLC First Patient Dosed in Breast Cancer TrialLSE:EVGEvgen Pharma Plc
17/01/201708:00UK RegulatoryEvgen Pharma PLC Appointment of CFO and Head of Clinical OperationsLSE:EVGEvgen Pharma Plc
11/01/201710:17Alliance NewsAlliance NewsEvgen Pharma Gets Positive Review For SFX-01 Phase II StudyLSE:EVGEvgen Pharma Plc
11/01/201708:00UK RegulatoryEvgen Pharma PLC Positive DSMB Review of SAS TrialLSE:EVGEvgen Pharma Plc
05/12/201611:01Alliance NewsAlliance NewsEvgen Pharma Eyeing Third Clinical Programme After First Half ProgressLSE:EVGEvgen Pharma Plc
05/12/201608:46UK RegulatoryEvgen Pharma PLC Half Yearly ReportLSE:EVGEvgen Pharma Plc
29/11/201612:53RNS Non-RegulatoryEvgen Pharma PLC Hardman Research: Clinical sulforaphane potentialLSE:EVGEvgen Pharma Plc
17/11/201608:01UK RegulatoryEvgen Pharma PLC Notice of Interim ResultsLSE:EVGEvgen Pharma Plc
01/11/201613:30UK RegulatoryEvgen Pharma PLC Grant of OptionsLSE:EVGEvgen Pharma Plc
15/09/201608:01UK RegulatoryEvgen Pharma PLC Update re SFX-01 Data at ECTRIMS 2016LSE:EVGEvgen Pharma Plc
08/09/201616:44Alliance NewsAlliance NewsEvgen Pharma Shares Rise On Back Of Teaser For SFX-01 ResultsLSE:EVGEvgen Pharma Plc
08/09/201616:30UK RegulatoryEvgen Pharma PLC Presentation of SFX-01 Data at ECTRIMS 2016LSE:EVGEvgen Pharma Plc
24/08/201616:29Alliance NewsAlliance NewsEvgen Pharma Says SFX-01 Granted Orphan Drug Designation In USLSE:EVGEvgen Pharma Plc
24/08/201616:15UK RegulatoryEvgen Pharma PLC Orphan Designation in the USA in SAHLSE:EVGEvgen Pharma Plc
17/08/201609:13Alliance NewsAlliance NewsEvgen Gains Approval For SFX-01 Breast Cancer Phase II Clinical TrialLSE:EVGEvgen Pharma Plc
17/08/201608:00UK RegulatoryEvgen Pharma PLC Approval for Phase II Study in Breast CancerLSE:EVGEvgen Pharma Plc
24/06/201616:36UK RegulatoryEvgen Pharma PLC Result of AGMLSE:EVGEvgen Pharma Plc
02/06/201608:00UK RegulatoryEvgen Pharma PLC Posting of Annual Report and AGM NoticeLSE:EVGEvgen Pharma Plc
31/05/201611:59Alliance NewsAlliance NewsEvgen Pharma Pleased With "Significant Progress" Since AIM ListingLSE:EVGEvgen Pharma Plc
31/05/201608:01UK RegulatoryEvgen Pharma PLC Final ResultsLSE:EVGEvgen Pharma Plc
09/05/201608:00UK RegulatoryEvgen Pharma PLC Notification of Preliminary ResultsLSE:EVGEvgen Pharma Plc
03/05/201609:42Alliance NewsAlliance NewsEvgen Pharma Doses First Patients In Phase 2 SFX-01 Trial For StrokeLSE:EVGEvgen Pharma Plc
03/05/201608:01UK RegulatoryEvgen Pharma PLC First Patient Dosed in Phase II TrialLSE:EVGEvgen Pharma Plc
02/03/201610:44Alliance NewsAlliance NewsEvgen Pharma Gets Approvals To Begin Phase II SFX-01 TrialLSE:EVGEvgen Pharma Plc
02/03/201608:01UK RegulatoryEvgen Pharma PLC Approval of Phase II Clinical Trial in SAHLSE:EVGEvgen Pharma Plc
19/01/201616:32Alliance NewsAlliance NewsCORRECT: DIRECTOR DEALINGS: Evgen Pharma Directors Buy 136,000 SharesLSE:EVGEvgen Pharma Plc
19/01/201616:23UK RegulatoryEvgen Pharma PLC Correction: Director Share PurchasesLSE:EVGEvgen Pharma Plc
19/01/201610:51Alliance NewsAlliance NewsDIRECTOR DEALINGS: Evgen Pharma Directors Bought 136,000 SharesLSE:EVGEvgen Pharma Plc
19/01/201608:00UK RegulatoryEvgen Pharma PLC Director Share PurchasesLSE:EVGEvgen Pharma Plc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:EVG
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network